drugset / Trial / NCT00993421

A Weight Loss Study in Overweight Men and Women

NCT00993421

Phase 2 Terminated 343 enrolled Eli Lilly and Company
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if LY377604 + sibutramine work better than LY377604 or sibutramine alone in the treatment of obesity.

Timeline

Start
2009-10
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject LY377604 Small molecule 15 mg Oral
Subject LY377604 Small molecule 40 mg Oral
Subject LY377604 Small molecule 75 mg Oral
Comparator Metoprolol Other / unclassified 200 mg Oral
Subject Sibutramine Small molecule 15 mg Oral
Subject Sibutramine Small molecule 30 mg Oral

Indications